February 16, 2016
Article
COMMENTARY
Big Data analyses are observational, raising threats to causal inference. Validity checks help, but we must not let enthusiasm about Big Data obscure the science.
February 16, 2016
Article
POLICY
This study identified 4 distinct medication adherence trajectories and found that continuity of care was consistently associated with medication adherence in every trajectory group.
February 16, 2016
Article
CLINICAL
Over a 10-year time frame, longitudinal adherence to current colorectal cancer (CRC) screening guidelines was less than ideal in a large, continuously insured US population at average risk for CRC.
February 16, 2016
Article
POLICY
A national survey of health plans shows that price estimator tools available to commercial plan enrollees provide price information for a variety of services at the provider level.
February 16, 2016
Article
MANAGERIAL
Geisinger Health System’s $0 co-pay drug program for its chronically ill employee population is associated with positive cost savings and a 5-year return-on-investment of approximately 1.8.
February 04, 2016
Article
WEB EXCLUSIVE
Re-analysis of US Preventive Services Task Force colorectal cancer screening guidelines shows that every-3-year screening with multi-target sDNA could address poor performance of recommended annual testing.
February 03, 2016
Article
WEB EXCLUSIVE
Assessment of the timing of histologic and molecular testing indicates that testing occurred prior to treatment initiation for most patients with metastatic non—small cell lung cancer.
February 02, 2016
Article
WEB EXCLUSIVE
This article analyzes use of lumbar spine magnetic resonance imaging in a national sample of patients with low back pain.
January 29, 2016
Article
WEB EXCLUSIVE
Medicare Advantage beneficiaries were 1.06 times more likely to receive mammography compared with fee-for-service (FFS) beneficiaries. FFS providers were less likely to recommend mammograms to racial/ethnic groups.
January 25, 2016
Article
WEB EXCLUSIVE
A systematic review of the impact and rationale for the selection of adjustment factors (case-mix factors) used to describe performance in diabetes care.